Uncategorized


January 29, 2025

Trump’s Attempt to Freeze Federal Spending Unlikely to Succeed

By Joe Lieber

We do not believe that the Trump administration will be successful in their attempts to freeze / cut federal funding that Congress authorized. However, we do see this attempt by the Trump administration as increasing…

Read More >>

January 28, 2025

[CNC, MOH, ARDT, UHS, ENSG, ADUS]: Medicaid Funding & Best Bet on OMB Funding Memo

By Beth Steindecker

We lean against yesterday’s OMB directive for temporarily pausing federal funding for grants, loans and programs applying largely to Medicaid’s payments to the states for Medicaid insurers (CNC, MOH, ELV, UNH, CVS) or for reimbursements…

Read More >>

January 27, 2025

Capitol Policy Weekly: Jan. 27-31

By Joe Lieber

We could see progress on a few fronts this week as Congress works on:   The massive reconciliation / tax bill legislation at a retreat starting today in Florida.  Top- line spending levels for defense and…

Read More >>

January 22, 2025

Trump Tariffs Update

By Joe Lieber

We have the following comments about President Trump’s recent trade pronouncements, which are generally consistent with our views before he became president. We are skeptical that the 25% tariffs on Mexico and Canada, in response…

Read More >>

January 22, 2025

[OSCR, CNC, HCA, THC, WELL] Optimistic on ACA Subsidies, But Watching Other Risks

By Beth Steindecker

While investors in insurers and providers seem most concerned about the fate of the expiring enhanced ACA subsidies, which we still expect to be revised but ultimately extended later this year, other – albeit smaller…

Read More >>

January 21, 2025

Guardant (GH) Reveal Medicare Coverage FAQ

By John Leppard

Following GH’s announcement this AM of Medicare coverage of its tissue-naïve Reveal test for minimal residual disease (MRD) surveillance testing, we wanted to highlight some additional salient points omitted from the company’s press release. The…

Read More >>

January 20, 2025

Capitol Policy Weekly: Jan. 20-24—Inauguration Special

By Joe Lieber

We expect some potential market moving action this week in relation to:  1) President-elect Trump’s inauguration, 2) his potential executive orders (EOs) and 3) his public comments. Trump has promised 100 EOs in the first…

Read More >>

January 17, 2025

[NVO, BHC, TEVA] Quantifying IRA Price Negotiation Risks

By John Leppard

Our analysis of the drugs included in the CY27 cycle of price negotiations under the Inflation Reduction Act (IRA) announced this morning implies a 3%-4% headwind for NVO relative to consensus CY27 revenues, with a…

Read More >>

January 17, 2025

MedPAC Provider Recs Likely to Be Ignored in Favor of Savings Targets Like Site Neutrality, Medicaid, Rule Repeals

By Beth Steindecker

We doubt Medicare Payment Advisory Commission’s (MedPAC) FY/CY26 Medicare payment recommendations for home health agencies, inpatient rehab facilities, skilled nursing facilities, hospices, dialysis centers, hospitals, and physician offices, which were voted on Thursday in nearly…

Read More >>

January 16, 2025

FY25 Defense Spending Iis Likely to Come in Above Our Expectations

By Joe Lieber

Our long-held belief has been that defense spending for FY25 would clock in at ~$920 billion; however, that figure seems too low in our view, given the recent news flow.  We now believe defense spending…

Read More >>